Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy - First results of the Halle Assist Induced Recovery study (HAIR)

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 1, 1999, Pages 48-50

  Milting, H ^a   Bartling, B ^a   Schumann, H ^a   El Banayosy, A ^b   Wlost, S ^b   Ruter F ^a,c   Darmer, D ^a   Holtz, J ^a   Korfer R ^b   Zerkowski, H R ^a,c,d  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Apoptosis; Bcl x(L); Dilated cardiomyopathy; Fas receptor; Reverse transcription polymerase chain reaction; Ventricular assist device

Indexed keywords

ADULT; APOPTOSIS; ARTICLE; CALIBRATION; CLINICAL ARTICLE; DISEASE SEVERITY; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART DILATATION; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032895304     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013108     Document Type: Article

References (22)

1. Tayama E, Nose Y. Can we treat dilated cardiomyopathy using a left ventricular assist device. Artif Organs. 1996;20:197-201.
2. Keren A, Gottlieb S, Tzivoni D, et al. Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation. Circulation. 1990;81:506-17.
3. Hill JD, Farrar DJ, Hershon JJ, et al. Bridge to cardiac transplantation: successful use of prosthetic biventricular support in a patient awaiting a donor heart. ASAIO Trans. 1986;32:233-7.
4. Farrar DJ, Hill JD. Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Ann Thorac Surg. 1993;55:276-82.
5. Farrar DJ, Lawson JH, Litwak P, Lederwall G. Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant. 1990;9:415-22.
6. Frazier OH, Benedict CR, Radovancevic B, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62:675-81.
7. Westaby S, Jin XY, Katsumata T, Taggart DP, Coats AJS, Frazier OH. Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery. Ann Thorac Surg. 1997;64:1303-8.
8. Müller J, Wallukat G, Weng YG, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96:542-9.
9. Termuhlen DF, Swartz MT, Pennington DG, Samuels LD, McBride LR, Kanter KR, et al. Predictors for weaning patients from ventricular assist devices (VADs). ASAIO Trans. 1987;33:683-8.
10. James KB, McCarthy PM, Thomas JD, Vargo R, Hobbs RE, Sapp S, et al. Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure. Circulation. 1995;92(9 Suppl):II 191-5.
11. Hasper D, Hummel M, Kleber FX, et al. Inflammatory mediators in patients with biventricular assist device systems. Z Kardiol. 1996;85:820-7.
12. Anversa P, Kajstura J, Olivetti G. Myocyte death in heart failure. Curr Opin Cardiol. 1996;11:245-51.
13. Bing, OH. Hypothesis: apoptosis may be a mechanism for the transition to heart failure wich chronic pressure overload. J Mol Cell Cardiol. 1994;26:943-8.
14. Bartling, B, Holtz J, Darmer D. Contribution of myocyte apoptosis to myocardial infarction? Basic Res Cardiol. 1998;93:71-84.
15. Brömme HJ, Holtz J. Apoptosis in the heart: when and why? Mol Cell Biochem. 1996;163-164:261-75.
16. Schumann H, Morawietz H, Hakim H, et al. Alternative splicing of the primary transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium. Biochem Biophys Res Commun. 1997;239:794-8.
17. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-9.
18. Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91:2717-20.
19. Grunstein R, Belland SE, Jeevanandam V, Eisen HJ. The effect of sustained mechanical support on myocardial apoptosis in patients wich severe dilated cardiomyopathy. Circulation. 1997;96:I-372-3 (Abstract).
20. Cheng W, Li B, Kajstura J, et al. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-59.
21. Bartling B, Schumann H, Holtz J, Grapow M, Zerkowski HR, Darmer D. Die myokardiale Expression der mitochondrialen Bcl-Apoptose-Modulatoren ist bei Herzinsuffizienz vermindert und wird durch Therapie mit ACE-Hemmern teilweise normalisiert. Z Kardiol. 1998;87:192 (abstract).
22. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest. 1998; 101:1326-42.